{{Rsnum
|rsid=2838956
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Chromosome=21
|Orientation=plus
|Gene=SLC19A1
|position=45525110
|Gene_s=SLC19A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 34.3 | 55.6 | 10.2
| HCB | 26.7 | 42.2 | 31.1
| JPT | 13.6 | 59.1 | 27.3
| YRI | 1.6 | 42.9 | 55.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 26.7 | 42.2 | 31.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 26.0 | 52.0 | 22.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 48.3 | 36.2 | 15.5
| MKK | 0.0 | 0.0 | 0.0
| TSI | 37.4 | 46.5 | 16.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=25124723
|Title=SLC19A1, SLC46A1 and SLCO1B1 Polymorphisms As Predictors Of Methotrexate-Related Toxicity In Portuguese Rheumatoid Arthritis Patients
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}